[
  {
    "ts": "2025-11-20T04:43:15+00:00",
    "headline": "133-year-old big pharma company plans layoffs, files WARN notice",
    "summary": "Layoffs are increasing this year, and they're not limited to any one particular industry. We've previously seen high-profile layoffs from fast-growing technology stalwarts, including Amazon and Microsoft. Now, we've learned that Merck & Co., a 133-year-old drug manufacturer, also ...",
    "url": "https://www.thestreet.com/employment/133-year-old-big-pharma-company-plans-layoffs-files-warn-notice",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "09005181-59d5-317f-ba35-7fbe6fea8efb",
      "content": {
        "id": "09005181-59d5-317f-ba35-7fbe6fea8efb",
        "contentType": "STORY",
        "title": "133-year-old big pharma company plans layoffs, files WARN notice",
        "description": "",
        "summary": "Layoffs are increasing this year, and they're not limited to any one particular industry. We've previously seen high-profile layoffs from fast-growing technology stalwarts, including Amazon and Microsoft. Now, we've learned that Merck & Co., a 133-year-old drug manufacturer, also ...",
        "pubDate": "2025-11-20T04:43:15Z",
        "displayTime": "2025-11-20T04:43:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/5ce2ba0822fd139540aeb4684e445252",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9tshWq706Po_bbFa4QHS5w--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/5ce2ba0822fd139540aeb4684e445252.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/slv17lV7F4A7acUM4mCBwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/5ce2ba0822fd139540aeb4684e445252.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/employment/133-year-old-big-pharma-company-plans-layoffs-files-warn-notice",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/133-old-big-pharma-company-044315865.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-20T12:00:00+00:00",
    "headline": "Merck Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for WINREVAIR® (sotatercept)",
    "summary": "Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that it has successfully completed negotiations with the pan‑Canadian Pharmaceutical Alliance (pCPA) for WINREVAIR® (sotatercept). The pCPA negotiates on behalf of the provinces, territories, and federal drug programs serving as a critical step in bringing WINREVAIR® closer to public reimbursement.",
    "url": "https://finance.yahoo.com/news/merck-canada-pan-canadian-pharmaceutical-120000625.html",
    "source": "CNW Group",
    "provider": "yfinance",
    "raw": {
      "id": "a8d13f35-4482-3ec9-b88a-1a45520ddb13",
      "content": {
        "id": "a8d13f35-4482-3ec9-b88a-1a45520ddb13",
        "contentType": "STORY",
        "title": "Merck Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for WINREVAIR® (sotatercept)",
        "description": "",
        "summary": "Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that it has successfully completed negotiations with the pan‑Canadian Pharmaceutical Alliance (pCPA) for WINREVAIR® (sotatercept). The pCPA negotiates on behalf of the provinces, territories, and federal drug programs serving as a critical step in bringing WINREVAIR® closer to public reimbursement.",
        "pubDate": "2025-11-20T12:00:00Z",
        "displayTime": "2025-11-20T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cnwgroup.com/a31c818593c897369fcfa7d3a78ada87",
          "originalWidth": 148,
          "originalHeight": 44,
          "caption": "Merck Logo (PRNewsfoto/Merck)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/X5ECAuinb0c1ZNcmzcqSPA--~B/aD00NDt3PTE0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/cnwgroup.com/a31c818593c897369fcfa7d3a78ada87.cf.webp",
              "width": 148,
              "height": 44,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5dlM8l_JVcYrsCYpUwWlkA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/a31c818593c897369fcfa7d3a78ada87.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CNW Group",
          "url": "http://www.newswire.ca/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-canada-pan-canadian-pharmaceutical-120000625.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-canada-pan-canadian-pharmaceutical-120000625.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-20T11:57:00+00:00",
    "headline": "Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.",
    "summary": "Shares in the biotech company have surged on news of a big pharma takeover.",
    "url": "https://www.fool.com/investing/2025/11/20/cidara-therapeutics-is-up-85-heres-what-investors/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "64530ba8-3949-333c-836e-51b6a3d250e9",
      "content": {
        "id": "64530ba8-3949-333c-836e-51b6a3d250e9",
        "contentType": "STORY",
        "title": "Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.",
        "description": "",
        "summary": "Shares in the biotech company have surged on news of a big pharma takeover.",
        "pubDate": "2025-11-20T11:57:00Z",
        "displayTime": "2025-11-20T11:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/0ba667c2d6214259542a89f61e971a47",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A pair of biotech research scientists discuss their findings.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lkjfpLOK9N5WZPwFDmGVGA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/0ba667c2d6214259542a89f61e971a47.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tirVL9trwaB5xe5whp1JHw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/0ba667c2d6214259542a89f61e971a47.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/20/cidara-therapeutics-is-up-85-heres-what-investors/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cidara-therapeutics-over-100-heres-115700592.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]